JETEMA, Co., Ltd. (216080.KQ)

KRW 15130.0

(-2.64%)

Revenue Summary of JETEMA, Co., Ltd.

JETEMA, Co., Ltd.'s latest annual revenue in 2023 was 58.71 Billion KRW , up 27.66% from previous year.
JETEMA, Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 17.22 Billion KRW , up 13.38% from previous quarter.
JETEMA, Co., Ltd. reported a annual revenue of 45.99 Billion KRW in annual revenue 2022, up 38.44% from previous year.
JETEMA, Co., Ltd. reported a annual revenue of 33.22 Billion KRW in annual revenue 2021, up 60.81% from previous year.
JETEMA, Co., Ltd. reported a quarterly revenue of 17.22 Billion KRW for 2024 Q1, up 13.38% from previous quarter.
JETEMA, Co., Ltd. reported a quarterly revenue of 13.39 Billion KRW for 2023 Q1, down -4.89% from previous quarter.

Annual Revenue Chart of JETEMA, Co., Ltd. (2023 - 2017)

Historical Annual Revenue of JETEMA, Co., Ltd. (2023 - 2017)

Year	Revenue	Revenue Growth
2023	58.71 Billion KRW	27.66%
2022	45.99 Billion KRW	38.44%
2021	33.22 Billion KRW	60.81%
2020	20.65 Billion KRW	55.33%
2019	13.3 Billion KRW	18.67%
2018	11.2 Billion KRW	37.17%
2017	8.17 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	17.3 Billion KRW	0.46%
2024 Q1	17.22 Billion KRW	13.38%
2023 Q1	13.39 Billion KRW	-4.89%
2023 Q3	14.15 Billion KRW	-11.45%
2023 Q2	15.98 Billion KRW	19.33%
2023 FY	58.71 Billion KRW	27.66%
2023 Q4	15.19 Billion KRW	7.36%
2022 Q2	10.31 Billion KRW	7.27%
2022 Q1	9.61 Billion KRW	-5.59%
2022 Q3	11.98 Billion KRW	16.24%
2022 FY	45.99 Billion KRW	38.44%
2022 Q4	14.08 Billion KRW	17.46%
2021 Q3	7.29 Billion KRW	-11.05%
2021 Q4	10.18 Billion KRW	39.49%
2021 Q1	7.53 Billion KRW	-15.24%
2021 FY	33.22 Billion KRW	60.81%
2021 Q2	8.2 Billion KRW	8.94%
2020 Q3	6 Billion KRW	139.65%
2020 Q1	3.26 Billion KRW	-18.53%
2020 FY	20.65 Billion KRW	55.33%
2020 Q4	8.88 Billion KRW	48.0%
2020 Q2	2.5 Billion KRW	-23.17%
2019 Q3	2.94 Billion KRW	0.0%
2019 FY	13.3 Billion KRW	18.67%
2019 Q4	4 Billion KRW	36.12%
2019 Q1	2.85 Billion KRW	0.0%
2018 Q1	2.4 Billion KRW	0.0%
2018 FY	11.2 Billion KRW	37.17%
2017 FY	8.17 Billion KRW	0.0%

Peer Revenue Comparison of JETEMA, Co., Ltd.

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	-36.866%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	-512.555%
BINEX Co., Ltd.	154.82 Billion KRW	62.076%
Bioneer Corporation	263.23 Billion KRW	77.695%
Anterogen.Co.,Ltd.	6.5 Billion KRW	-803.29%
MEDIPOST Co., Ltd.	68.64 Billion KRW	14.462%
CrystalGenomics, Inc.	4.87 Billion KRW	-1103.528%
Helixmith Co., Ltd	4.2 Billion KRW	-1297.462%
Chabiotech Co.,Ltd.	953.95 Billion KRW	93.845%
Medy-Tox Inc.	221.12 Billion KRW	73.446%
Peptron, Inc.	3.34 Billion KRW	-1656.97%
Amicogen, Inc.	159.9 Billion KRW	63.28%
Genexine, Inc.	4.42 Billion KRW	-1226.429%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	-9.241%
LegoChem Biosciences, Inc.	34.14 Billion KRW	-71.958%
ALTEOGEN Inc.	96.52 Billion KRW	39.169%
PharmaResearch Co., Ltd.	261.01 Billion KRW	77.504%
SillaJen, Inc.	3.93 Billion KRW	-1390.423%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	-244.088%
Genomictree Inc.	3.41 Billion KRW	-1617.844%
MedPacto, Inc.	- KRW	-Infinity%
D&D Pharmatech	18.67 Billion KRW	-214.376%
EASY BIO,Inc.	165.38 Billion KRW	64.497%
GI Innovation, Inc.	5.31 Billion KRW	-1003.924%